News | January 18, 2007

Biosense Webster Forges Big-Name Alliances

Jan. 19, 2007 — Biosense Webster made two agreements public this week with healthcare competitor modality giants Philips and Siemens.

On Jan. 16 the company announced it has agreed to co-develop integrated products with Philips that will simplify complex procedures to diagnose and treat irregular heartbeats, also known as arrhythmias. Two days later Biosense and Siemens announced an extension of their strategic alliance to now give Biosense Webster exclusive worldwide rights to distribute Siemens' ACUSON AcuNav ultrasound catheters to interventional cardiologists.

Biosense Websters value as a key player in the electrophysiology and interventional cardiology market is underscored by the large-scale and high-profile deals immediately out of the 2007 gate. The Siemens agreement is an expansion of an arrangement penned earlier this month that gave Biosense Webster exclusive distribution rights to market Siemens’ catheter to electrophysiologists.

Siemens says the expanded strategic alliance will enable the two companies to address the real-time imaging needs of interventional cardiologists.

Siemens AcuNav ultrasound catheters provide physicians with high quality diagnostic images and Doppler blood flow information throughout the entire heart during a cardiac catheterization procedure, the manufacturer states. Approved for marketing in 1999, AcuNav ultrasound catheters are known for state-of-the-art quality and are currently the world's leading cardiac imaging catheters, the company asserts.

"The integration of these two industry leaders, both focused on providing high quality intracardiac echocardiography products will help physicians improve care for the cardiac patient," said Robert J. Sommer, M.D., New York-Presbyterian Hospital/Columbia University Medical Center. "Clinicians are looking forward to the innovative products that this collaboration will provide to the medical community."

Biosense Webster is a key player in the electrophysiology and interventional cardiology market and Siemens is an ultrasound industry leader.

Meanwhile, the alliance between Philips and Biosense Webster will enable the creation of an interface that connects Biosense Webster’s Carto Mapping and Navigation System with Philips’ integrated Allura Xper electrophysiology (EP) Lab System — with the objective of helping reduce the amount of time required to setup and perform complex electrophysiology (EP) ablation procedures.

Carto will also be integrated with Philips’ Xcelera Cardiovascular Information Solution.

Related Content

Biotronik Announces U.S. Launch of Edora HF-T QP CRT Pacemaker
Technology | Cardiac Resynchronization Therapy Devices (CRT)| August 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and commercial availability of Edora HF-T QP, an...
The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Oregon Tech Partners with Mindray for High-Tech Ultrasound Education
News | Ultrasound Imaging| August 04, 2017
To better prepare its ultrasound students to compete and thrive in the evolving healthcare environment, Oregon...
Carestream Shows Touch Prime Systems at Society for Vascular Ultrasound Conference
News | Cardiovascular Ultrasound| August 03, 2017
Carestream will showcase its Carestream Touch Prime and Touch Prime XE Ultrasound Systems at the Society for Vascular...
Merge Hemo cath lab hemodynamics monitoring system.

Hemodynamic data shown on screens from the Merge Hemo recording system. It is among the newer generation hemodynamic systems for cath labs that are more user friendly and have technologies to speed workflow.

Feature | Hemodynamic Monitoring Systems| August 03, 2017 | Dave Fornell
The current generation of...
Left Atrial Pressure Monitor from Vectorious Medical Technologies Offers New Hope for Heart Failure Patients

On of the top stories in July was the introduction of a left atrial pressure monitor from Vectorious Medical Technologies to prevent heart failure patient hospitalizations or readmissions. Read the article"Left Atrial Pressure Monitor Offers New Hope for Heart Failure Patients."

Feature | August 01, 2017 | Dave Fornell
Aug.
Ohio State Researchers Prove Human Heart's 'Battery' Has Multiple Backups
News | EP Lab| July 27, 2017
July 27, 2017 — There is good news when it comes to the heart’s sinoatrial node (SAN), the body’s natural...
Overlay Init